TCID is a potent and selective inhibitor of ubiquitin C-terminal hydrolase L3 (UCH-L3) with an IC50 of 0.6 µM, demonstrating 125-fold selectivity over UCH-L1. This small molecule probe is used in biochemical and cellular studies to investigate deubiquitinase function, protein homeostasis, and related disease pathways in vitro.